MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhou, Jianwen ^a   Wang, Wei ^b,e   Gao, Zhenhua ^a   Peng, Xueling ^a,f   Chen, Xulin ^a   Chen, Wei ^c   Xu, Weiyi ^a   Xu, Haixiong ^a   Lin, Marie C ^d   Jiang, Songshan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

^e HuaBo Bio Pharmaceutic Institute of Guangzhou   (China)

^f Shenzhen High Tech Industrial Estate   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GLIOBLASTOMA; HUMANS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; TUMOR SUPPRESSOR PROTEINS;

EID: 84893447071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083055     Document Type: Article

References (47)

1. Zhang Y, Dutta A, Abounader R (2012) The role of microRNAs in glioma initiation and progression. Front Biosci (Landmark Ed) 17: 700-712.
2. Xu X, Xi L, Zeng J, Yao Q (2012) A Functional+61G/A Polymorphism in Epidermal Growth Factor Is Associated with Glioma Risk among Asians. PLoS One 7: e41470.
3. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, et al. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777-786.
4. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, et al. (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89: 349-356. (Pubitemid 27220879)
5. Lee TC, Ziff EB (1999) Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. Journal of Biological Chemistry 274: 595-606.
6. Schreiber-Agus N, Meng Y, Hoang T, Hou H, Chen K, et al. (1998) Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393: 483-487. (Pubitemid 28292197)
7. Wechsler DS, Hawkins AL, Li X (1994) Localization of the human Mxi1 transcription factor gene (MXl1) to chromosome 10q24-q25. Genomics 21: 669-672. (Pubitemid 24189908)
8. Edelhoff S, Ayer DE, Zervos AS, Steingrimsson E, Jenkins N, et al. (1994) Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXII to human chromosome 10 and mouse chromosome 19. Oncogene-Basingstoke 9: 665-665.
9. Wang DY, Xiang YY, Li XJ, Hashimoto M, Tanaka M, et al. (2000) Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines. Pathology International 50: 373-383. (Pubitemid 30451480)
10. Prochownik EV, Grove LE, Deubler D, Zhu XL, Stephenson RA, et al. (1998) Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes, Chromosomes and Cancer 22: 295-304. (Pubitemid 28304520)
11. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin N, et al. (1995) Mutation of the MXI1 gene in prostate cancer. Nature genetics 9: 249-255.
12. Li XJ, Wang DY, Zhu Y, Guo RJ, Wang XD, et al. (1999) Mxi1 mutations in human neurofibrosarcomas. Cancer Science 90: 740-746. (Pubitemid 29381103)
13. Kawamata N, Park D, Wilczynski S, Yokota J, Koeffler HP (2007) Point mutations of the Mxil gene are rare in prostate cancers. The Prostate 29: 191-193.
14. Wechsler DS, Shelly CA, Petroff CA, Dang CV (1997) MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer research 57: 4905-4912. (Pubitemid 27469001)
15. Fults D, Pedone C, Thompson G, Uchiyama C, Gumpper K, et al. (1998) Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int J Oncol 12: 905.
16. Skotheim RI, Monni O, Mousses S, Fossa SD, Kallioniemi OP, et al. (2002) New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 62: 2359-2364. (Pubitemid 34411718)
17. Manni I, Tunici P, Cirenei N, Albarosa R, Colombo B, et al. (2002) Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression. British Journal of Cancer 86: 477-484. (Pubitemid 34185136)
18. Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
19. Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482: 347-355.
20. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611. (Pubitemid 46683148)
21. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, et al. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249. (Pubitemid 41404155)
22. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739. (Pubitemid 34455427)
23. Tam W (2001) Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274: 157-167.
24. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627-3632. (Pubitemid 40354662)
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
26. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
27. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358. (Pubitemid 41074723)
28. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
29. Zhou X, Ren Y, Moore L, Mei M, You Y, et al. (2010) Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90: 144-155.
30. Rao SA, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23: 1404-1417.
31. Lavon I, Zrihan D, Granit A, Einstein O, Fainstein N, et al. (2010) Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol 12: 422-433.
32. Lages E, Guttin A, El Atifi M, Ramus C, Ipas H, et al. (2011) MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS One 6: e20600.
33. Skalsky RL, Cullen BR (2011) Reduced expression of brain-enriched micro-RNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 6: e24248.
34. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, et al. (2011) Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One 6: e14681.
35. Zhou P, Xu W, Peng X, Luo Z, Xing Q, et al. (2013) Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 39UTR of a Gene Is Targeted by Multiple miRNAs. PLoS One 8: e68204.
36. Xu W, Liu M, Peng X, Zhou P, Zhou J, et al. (2013) miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42: 757-766.
37. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153: 654-665.
38. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859. (Pubitemid 350258623)
39. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
40. Tam W, Ben-Yehuda D, Hayward WS (1997) bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17: 1490-1502. (Pubitemid 27097379)
41. Clurman B, Hayward W (1989) Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol 9: 2657-2664. (Pubitemid 19148141)
42. Tam W, Hughes SH, Hayward WS, Besmer P (2002) Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 76: 4275-4286. (Pubitemid 34309563)
43. Teng G, Papavasiliou FN (2009) Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci 364: 631-637.
44. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070. (Pubitemid 41161233)
45. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. (Pubitemid 43357945)
46. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, et al. (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126: 73-80.
47. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608. (Pubitemid 351656494)